Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal Pharma (MDGL) Tops Q3 EPS by $1.84, Beats on Revenue

October 31, 2024 7:05 AM EDT

Madrigal Pharma (NASDAQ: MDGL) reported Q3 EPS of ($4.92), $1.84 better than the analyst estimate of ($6.76). Revenue for the quarter came in at $62.2 million versus the consensus estimate of $34.09 million.

For earnings history and earnings-related data on Madrigal Pharma (MDGL) click here.

... More